Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

Talkspace (NASDAQ: TALK), the provider of virtual behavioral-health services, just made a move that builds on the bull thesis ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

BriaCell Therapeutics recently closed an $8.5 million stock sale after its positive results from mid-stage testing of its ...

We circle back to three small biotech stocks that recently were positively highlighted and moved up on good news. Explore ...

Vanda pharmeucitals received a rejection for its drug tradipitant, causing the company management to criticize the FDA.

CYB003: A proprietary deuterated psilocin program with FDA Breakthrough Therapy ... its business, it may have a material adverse effect on Cybin’s performance and operations. Neither the Cboe Canada ...

AstraZeneca (LSE:AZN) is navigating a period of robust growth and strategic challenges. Recent developments include an 18% ...

Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, ...

Kineta will be trading under the symbol “KANT” on OTC PinkKineta will continue to pursue strategic alternatives as previously announcedTuHURA ...

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with ...

FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S.Phase 3 study for ...